Dentsply International is an American company, based in York, Pennsylvania, that develops, manufactures and markets consumable dental products for the professional dental market.
The company is publicly listed on the NASDAQ Stock Market under the stock ticker symbol ‘XRAY’.
Dentsply’s main product categories are dental consumable products, consumable medical device products, dental specialty products, and dental laboratory products.
Dental consumable products – dental anesthetics, prophylaxis paste, dental sealants, impression materials, restorative materials, tooth whiteners, topical fluoride, dental handpieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
Consumable medical products – urology catheters, certain surgical products, medical drills and other non-medical products.
Dental specialty products – endodontic (root canal) instruments and materials, implants and related products, bone grafting materials, 3D digital scanning and treatment planning software, dental lasers and orthodontic appliances and accessories.
Dental laboratory products – precious metal dental alloys, artificial teeth, dental ceramics and crown and bridge materials, computer aided design and machining (CAD/CAM) ceramic systems, and porcelain furnaces.
The company dates its history back to 1899 as an artificial teeth and dental consumable products manufacturer and distributor incorporated as “Dentists’ Supply Company” – founded by four businessmen in New York.
Overview
- Chairman and CEO: Bret W. Wise
- President and CFO: Christopher T. Clark
- Type: Public
- Industry: Dental Equipment
- Publicly listed on the NASDAQ Stock Market
- NYSE stock ticker symbol: XRAY
- S&P 500 Component
- Revenue: $2.950 billion USD (2013)
- Net income: $318 million USD (2013)
- Diluted earnings per share: $2.16 USD (2013)
- Founded: 1899
- Employees: 11,800 (2013)
- Corporate headquarters: 221 West Philadelphia Street, York, PA, USA
- Corporate contact number: (717) 845-7511
- Investor relations contact number: (717) 849-7863
- Investor relations email address: [email protected]
- Website: http://www.dentsply.com/
| Operating data (in $ thousands) | 2013 | 2012 |
| Net sales | $2,950,770 | $2,928,429 |
| Cost of products sold | $1,373,358 | $1,372,042 |
| Gross profit | $1,577,412 | $1,556,387 |
| Selling, general and administrative expenses | $1,144,890 | $1,148,731 |
| Restructuring and other costs | $13,356 | $25,717 |
| Operating income | $419,166 | $381,939 |
| Income before income taxes | $369,335 | $330,679 |
| Provision for income taxes | $52,150 | $8,920 |
| Net income | $318,161 | $318,489 |
| Net income attributable to noncontrolling interests | $4,969 | $4,276 |
| Net income attributable to DENTSPLY International | $313,192 | $314,213 |
| Comprehensive income attributable to DENTSPLY International | $388,330 | $360,983 |
| Balance sheet data (in $ thousands) | ||
| Total assets | $5,078,047 | $4,972,297 |
| Total liabilities | $2,500,073 | $2,722,854 |
| Total DENTSPLY International Equity | $2,535,053 | $2,208,698 |
| Cash flow data (in $ thousands) | ||
| Net cash provided by operating activities | $417,846 | $369,685 |
| Net cash used in investing activities | $(260,231) | $(115,021) |
| Net cash used in financing activities | $(161,685) | $(255,609) |
| Cash and cash equivalents at end of period | $74,954 | $80,132 |
| Common share data (in $) | ||
| Basic earnings (loss) per common share | $2.20 | $2.22 |
| Diluted earnings (loss) per common share | $2.16 | $2.18 |
Source: “Dentsplt International Inc. 2013 FORM 10-K Annual Report”